Benralizumab/vedolizumab
Benralizumab
Benralizumab/mepolizumab
Benralizumab/Mepolizumab
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis
Benralizumab/dupilumab